Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
Retrieved on:
Wednesday, September 21, 2022
Group, National Biotechnology Research Park, Education, Agriculture, Faculty, Dean, Health, Industry, Letter, Genetics, LOI, Natural Resources, Student, Universiti Malaysia Sabah, Goal, B cell, Food security, Genomics, Biosafety, Faculty of Science, Mahidol University, Research, R, University, Cancer, UMS, CAR, Pharmaceutical industry, Management, Science
Parties agree to collaborate on research in genetics, regenerative and alternative medicine
Key Points:
- Parties agree to collaborate on research in genetics, regenerative and alternative medicine
PETALING JAYA, Malaysia, Sept 21, 2022 - (ACN Newswire) - Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. - Chairman of Malaysian Genomics, Datuk Seri Dr. Chen Chaw Min, said, "We are happy to assist UMS undergraduates in pursuing their R&D goals so that they have a better understanding of their field of study.
- The signing of the LOI followed UMS' visit to MGRC's Biosafety Level 2 cGMP (Current Good Manufacturing Practice)-certified laboratory, which is used for the production of cell therapies, including CAR T-cell therapies for various cancers.
- Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
Copyright 2022 ACN Newswire .